FDA recall D-0566-2016

Teva Pharmaceuticals USA · Class II · drug

Product

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.

Reason for recall

Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2015-11-12
Report date
2016-01-20
Termination date
2016-11-01
Voluntary/Mandated
Voluntary: Firm initiated
Location
North Wales, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0566-2016